ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
https://scientific-jl.org/obr
Выпуск журнала №-71
Часть–2_ июня–2025
72
2181-
3187
TYPES OF VACCINES AGAINST COVID-19 AND ABOUT THEM
Muhammadiyeva.F.R.
mukhammadiyeva.farida@mail.ru bsmi.uz
Bukhara State Medical Institute
,
(998) 65-223-00-50, bsmi.uz
Summary: Covid-19 infection is very dangerous and its complications can be
severe, so vaccination against infection is the most effective way. Several vaccines have
been developed to combat the infection, but their effectiveness varies. For this reason,
only highly effective and safe vaccines are used to prevent infection.
Key words: infection, vaccine, epidemiology, clinic, effectiveness.
A
vaccine
against
COVID-19, combined with
effective testing and existing
preventive measures, will
become an important tool to
help bring the pandemic
under control.
The threat to children from COVID-19 is enormous and goes far beyond the
immediate physical effects of the disease. Declining levels of routine health care
coverage and a looming recession threaten the health and future of a generation of
children.
Developing a safe and effective vaccine will take time, but thanks to an
unprecedented investment in research, development and global collaboration, scientists
are developing a vaccine against COVID-19 in record time, while adhering to
evidence-based and rigorous regulatory standards. they took
Still, it's important to remember that it's a long process from developing a vaccine
to licensing it, then mass production and widespread use. Once a vaccine receives the
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
https://scientific-jl.org/obr
Выпуск журнала №-71
Часть–2_ июня–2025
73
2181-
3187
necessary approval, it is important to deliver it in a timely and equitable manner to
those who need it most.
Vaccines work by mimicking viruses, bacteria, or other microorganisms that can
cause an infectious disease. This "trains" our immune system to respond quickly and
effectively against it.
Traditionally, vaccines do this by introducing a weakened form of an infectious
disease that remains in the memory of our immune system. This way, our immune
system can quickly recognize and fight the infection before it makes us sick. This is
exactly how vaccines against COVID-19 are currently being developed.
New approaches have also been used for other potential vaccines under
development: they are called RNA and DNA vaccines. Instead of injecting antigens (a
substance that causes your immune system to make antibodies), RNA and DNA
vaccines give our div the genetic code that allows our immune system to make the
antigen it needs on its own.
Each country has regulatory bodies that monitor the safety and effectiveness of
vaccines before they are widely used. Globally, WHO coordinates a number of
independent technical bodies that review the safety of vaccines before and even after
they are introduced. Vaccines approved for use by the WHO undergo rigorous testing
and clinical trials to demonstrate that they are safe and effective in fighting disease.
Although vaccines against COVID-19 are in the early stages of development, they can
only receive the necessary regulatory approvals if they meet strict safety and efficacy
standards.
The safety of children and their families, including safe vaccine delivery, is a top
priority for UNICEF.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
https://scientific-jl.org/obr
Выпуск журнала №-71
Часть–2_ июня–2025
74
2181-
3187
The high global demand for
the vaccine means that not
everyone can get the vaccine at
the same time. It will take months
or even years to make enough
vaccine doses for everyone
around the world.
In order to limit the impact
of COVID-19 on the functioning
of health and social systems, vaccination of health and school personnel will be carried
out first. Subsequent rounds of vaccine doses will allow participating countries to
vaccinate high-risk groups, including the elderly and people with severe medical
conditions who are at greater risk of serious illness and death after contracting COVID-
19.
References:
1. China Center for Disease Control and Prevention. Novel Coronavirus Pneumonia
Emergency Epidemiology Response Team. Vital Observations: Epidemiologic
Features of the 2019 Novel Coronavirus Disease (COVID-19) [Electronic resource].
- China, 2020. - No. 2 (8). - R. 113-122. - doi: 10.46234/ccdcw2020.032. Mode Login:
http://www.chinacdc. cn/en/COVID19/
2. Xie Y, You Q, Wu C, Cao S, Qu G, Yan X, Han X, Wang C, Zhang H. Cardiovascular
characteristics and clinical outcomes of activated coronavirus disease 2019 (COVID-
19) Circ. J. 2020 doi: 10.1253/circj.CJ-20-0348.
3. The WHO/World Health Organization (WHO) officially named this trigger "2019-
ncov" (new coronavirus 2019 dgia) January 12 situation report, 11. 2020.
4. World Health Organization. Novel coronavirus (2019-nCoV): situation report - 40.
[Electronic resource]. - WHO, 2021. - Access mode: https://www.who.int/docs/default
source/koronavirus/situation-reports/20200229
sitrep-40-covid-19.pdf.
(date
06/01/2022)
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
https://scientific-jl.org/obr
Выпуск журнала №-71
Часть–2_ июня–2025
75
2181-
3187
5. Global overview and references: characteristics of the epidemiological covid-19
pandemic
6. Rakhmanova J.A., Strategy of vaccines against COVID-19 in the Republic of
Uzbekistan; Journal of Rehealth. ISNN 2181-0443 DOI: 10.24411/2181-
0443.Tashkent 2021.143-page 147
7. Rakhmanova J.A. "Central Asian Journal of Medicine" Vol. 2022: Iss. 1, Article 5.
2022
8.
11. Muhammadiyeva. F. R. (2023). Changes in kidney microstructure in acetic
acid poisoning. SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES,
2(12), 584–586.
